Shares in GSK fell around 9% this morning after a judge in a Delaware court gave the green light for tens of thousands of lawsuits claiming harm by gastrointestinal drug Zantac to proceed to trial.

GSK and other drugmakers have lost no time in filing an appeal to a Delaware court’s decision to allow more than 70,000 Zantac-related lawsuits to go ahead. Just over a week ago, Judge Vivian ...

Oral phenylephrine was shown to be ineffective for treating nasal congestion over a year go. This week, the FDA took the ...

While introducing Windows 11, Microsoft made sure to make it more convenient for users in comparison to its predecessors. A lot of features that were not available in earlier versions of Windows ...

After hours: November 12 at 6:23 PM EST Loading Chart for SAFE ...

Here, we list smartphones that have received an overall rating of 8 or higher in Gadgets 360’s exhaustive, extremely in-depth reviews. Phones on this comprehensive list were launched in the past one ...